Literature DB >> 19046400

The roles of microRNA in cancer and apoptosis.

Niamh Lynam-Lennon1, Stephen G Maher, John V Reynolds.   

Abstract

microRNAs (miRNAs) are highly conserved, non-protein-coding RNAs that function to regulate gene expression. In mammals this regulation is primarily carried out by repression of translation. miRNAs play important roles in homeostatic processes such as development, cell proliferation and cell death. Recently the dysregulation of miRNAs has been linked to cancer initiation and progression, indicating that miRNAs may play roles as tumour suppressor genes or oncogenes. The role of miRNAs in apoptosis is not fully understood, however, evidence is mounting that miRNAs are important in this process. The dysregulation of miRNAs involved in apoptosis may provide a mechanism for cancer development and resistance to cancer therapy. This review examines the biosynthesis of miRNA, the mechanisms of miRNA target regulation and the involvement of miRNAs in the initiation and progression of human cancer. It will include miRNAs involved in apoptosis, specifically those miRNAs involved in the regulation of apoptotic pathways and tumour suppressor/oncogene networks. It will also consider emerging evidence supporting a role for miRNAs in modulating sensitivity to anti-cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19046400     DOI: 10.1111/j.1469-185X.2008.00061.x

Source DB:  PubMed          Journal:  Biol Rev Camb Philos Soc        ISSN: 0006-3231


  168 in total

Review 1.  Cell-free microRNAs as cancer biomarkers: the odyssey of miRNAs through body fluids.

Authors:  Mohammad Amin Javidi; Amir Hossein Ahmadi; Babak Bakhshinejad; Nazila Nouraee; Sadegh Babashah; Majid Sadeghizadeh
Journal:  Med Oncol       Date:  2014-11-02       Impact factor: 3.064

2.  Slowly produced microRNAs control protein levels.

Authors:  Zakary L Whichard; Adilson E Motter; Peter J Stein; Seth J Corey
Journal:  J Biol Chem       Date:  2010-11-04       Impact factor: 5.157

3.  A sensitive switch for visualizing natural gene silencing in single cells.

Authors:  Karmella A Haynes; Francesca Ceroni; Daniel Flicker; Andrew Younger; Pamela A Silver
Journal:  ACS Synth Biol       Date:  2012-03-16       Impact factor: 5.110

4.  Modulation of inflammatory markers by miR-146a during replicative senescence in trabecular meshwork cells.

Authors:  Guorong Li; Coralia Luna; Jianming Qiu; David L Epstein; Pedro Gonzalez
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-06       Impact factor: 4.799

Review 5.  The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma.

Authors:  Muhammad Nauman Aftab; Marcel E Dinger; Ranjan J Perera
Journal:  Arch Biochem Biophys       Date:  2014-07-24       Impact factor: 4.013

Review 6.  Pancreatic cancer stem cells.

Authors:  Ya-Yun Zhu; Zhou Yuan
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

7.  MicroRNA-127 is aberrantly downregulated and acted as a functional tumor suppressor in human pancreatic cancer.

Authors:  Yuan Yu; Lei Liu; Ruirui Ma; Haibing Gong; Ping Xu; Congjun Wang
Journal:  Tumour Biol       Date:  2016-08-29

8.  Triple-negative and luminal A breast tumors: differential expression of miR-18a-5p, miR-17-5p, and miR-20a-5p.

Authors:  Carlos Marino Cabral Calvano Filho; Daniele Carvalho Calvano-Mendes; Kátia Cândido Carvalho; Gustavo Arantes Maciel; Marcos Desidério Ricci; Ana Paula Torres; José Roberto Filassi; Edmund Chada Baracat
Journal:  Tumour Biol       Date:  2014-05-09

9.  miR-217-5p induces apoptosis by directly targeting PRKCI, BAG3, ITGAV and MAPK1 in colorectal cancer cells.

Authors:  Marion Flum; Michael Kleemann; Helga Schneider; Benjamin Weis; Simon Fischer; René Handrick; Kerstin Otte
Journal:  J Cell Commun Signal       Date:  2017-09-14       Impact factor: 5.782

10.  MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCs.

Authors:  Liqin Du; Jeoffrey J Schageman; Luc Girard; Scott M Hammond; John D Minna; Adi F Gazdar; Alexander Pertsemlidis
Journal:  J Exp Clin Cancer Res       Date:  2010-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.